Video wird geladen...

Video konnte nicht geladen werden

Beim Laden dieses Videos ist ein Problem aufgetreten. Dies könnte an einem vorübergehenden Netzwerkproblem liegen oder das Video ist möglicherweise nicht verfügbar.

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative... stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhDshow more

Dr. William Makis MD

647,838 subscribers

48,226 Aufrufe • vor 7 Monaten •via X (Twitter)

Gesundheit & Wellness Wissenschaft & Technologie

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,072 Aufrufe • vor 1 Monat

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 Aufrufe • vor 1 Monat

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 Aufrufe • vor 2 Jahren

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 Aufrufe • vor 1 Jahr

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 Aufrufe • vor 6 Monaten

Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin has multiple anti-cancer effects. “There are at least nine perfectly defined cancer targets affected by ivermectin,” oncologist Dr. Alfonso Dueñas-González, told The Epoch Times. The news outlet reported: "It [ivermectin] has a broad impact on the immune system, increasing immune offense against cancers." "It also inhibits cancer cell cycles, helping prevent the formation of new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells." Dr. Kathleen Ruddy, a cancer surgeon, observed a resounding improvement in three patients under her consultation after they started using ivermectin with additional therapies. One patient, facing terminal stage 4 prostate cancer and given only three weeks to live after all treatments failed, began using ivermectin. Remarkably, within two months, his indicators of prostate cancer plummeted, and by six months, his cancer had significantly receded. Less than a year later, he was energetically dancing for four hours, three nights a week. This miraculous recovery was not isolated, as two more patients experienced similar outcomes. Dr. Ruddy, with over 30 years in cancer surgery, reflected on these cases, saying, “I’ve been a cancer surgeon for over 30 years. I’ve never seen anything like this in one patient—let alone three in a row.” Read the full report in the comment below:

Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. But the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin has multiple anti-cancer effects. “There are at least nine perfectly defined cancer targets affected by ivermectin,” oncologist Dr. Alfonso Dueñas-González, told The Epoch Times. The news outlet reported: "It [ivermectin] has a broad impact on the immune system, increasing immune offense against cancers." "It also inhibits cancer cell cycles, helping prevent the formation of new cancer cells. The drug promotes the killing of cancer cells by inducing mitochondrial stress and prevents cancer survival by preventing new blood vessels, which transport energy and fuel to cancers, from forming near cancer cells." Dr. Kathleen Ruddy, a cancer surgeon, observed a resounding improvement in three patients under her consultation after they started using ivermectin with additional therapies. One patient, facing terminal stage 4 prostate cancer and given only three weeks to live after all treatments failed, began using ivermectin. Remarkably, within two months, his indicators of prostate cancer plummeted, and by six months, his cancer had significantly receded. Less than a year later, he was energetically dancing for four hours, three nights a week. This miraculous recovery was not isolated, as two more patients experienced similar outcomes. Dr. Ruddy, with over 30 years in cancer surgery, reflected on these cases, saying, “I’ve been a cancer surgeon for over 30 years. I’ve never seen anything like this in one patient—let alone three in a row.” Read the full report in the comment below:

The Vigilant Fox 🦊

1,192,290 Aufrufe • vor 2 Jahren

"I think deuterium is the reason why you have cancer." — Stephanie Seneff, MIT researcher. Deuterium is a heavy form of hydrogen naturally present in water and food. Your mitochondria are extremely sensitive to it — too much deuterium disrupts their ability to produce ATP and triggers excess reactive oxygen species. When deuterium accumulates systemically, every cell in your body starts struggling. Seneff's hypothesis: A cell senses the overload and transforms itself into a cancer cell. Not to harm you. To help you. Cancer cells abandon their normal function and obsess on one thing: duplicating themselves. Their metabolism shifts entirely. They suppress oxidative phosphorylation — the process by which mitochondria generate ATP using oxygen — repurposing them toward anabolic synthesis — to avoid the reactive oxygen species that high deuterium would generate. Instead they run glycolysis. Massive glucose intake. The output: lactate — carrying a deuterium-depleted proton — shipped out into circulation. Low-deuterium fuel delivered to the host. The cancer cell also relocates its V-ATPase pumps — protein pumps embedded in the cell membrane — to the outer surface, pumping deuterium-depleted protons directly into the tumor microenvironment — while hoarding deuterium inside itself. It is self-sacrificial. Taking on the burden so the rest of the body doesn't have to. Immune cells flood the tumor. But they don't attack. The cancer is nourishing them — lactate and deuterium-depleted protons — providing what their damaged mitochondria need to recover. Seneff notes the same lactate and low pH environment also signals immune cells to stand down — suppressing activation and allowing the tumor to survive in the process. Once the immune cells recover, they turn on the tumor and clear it. When deuterium levels drop low enough — the cancer cell's job is done. It undergoes apoptosis. Gabor Somlyai, Hungarian biochemist and cancer researcher showed that when cancer cells are placed in deuterium-depleted water, they stop multiplying and undergo apoptosis. In high-deuterium water — they thrive. He documented patients rejected by mainstream oncology — told to go home and die. They began drinking deuterium-depleted water. Some lived far beyond predicted life expectancy. Some achieved complete recovery. This also might explain why the ketogenic diet works against cancer. Animal fats are the lowest deuterium macronutrient. A ketogenic state naturally lowers systemic deuterium intake. Combined with glucose restriction — cancer cells depend heavily on glucose to run glycolysis — both mechanisms rest on the same biology. Thomas Seyfried, Professor of Biology at Boston College, reached the conclusion that cancer is a mitochondrial metabolic disease, not a genetic one. Seneff goes one step further: deuterium overload is why the mitochondria malfunction in the first place. According to her, cancer isn't a random malfunction. It's a coordinated biological response to a systemic deuterium overload.

"I think deuterium is the reason why you have cancer." — Stephanie Seneff, MIT researcher. Deuterium is a heavy form of hydrogen naturally present in water and food. Your mitochondria are extremely sensitive to it — too much deuterium disrupts their ability to produce ATP and triggers excess reactive oxygen species. When deuterium accumulates systemically, every cell in your body starts struggling. Seneff's hypothesis: A cell senses the overload and transforms itself into a cancer cell. Not to harm you. To help you. Cancer cells abandon their normal function and obsess on one thing: duplicating themselves. Their metabolism shifts entirely. They suppress oxidative phosphorylation — the process by which mitochondria generate ATP using oxygen — repurposing them toward anabolic synthesis — to avoid the reactive oxygen species that high deuterium would generate. Instead they run glycolysis. Massive glucose intake. The output: lactate — carrying a deuterium-depleted proton — shipped out into circulation. Low-deuterium fuel delivered to the host. The cancer cell also relocates its V-ATPase pumps — protein pumps embedded in the cell membrane — to the outer surface, pumping deuterium-depleted protons directly into the tumor microenvironment — while hoarding deuterium inside itself. It is self-sacrificial. Taking on the burden so the rest of the body doesn't have to. Immune cells flood the tumor. But they don't attack. The cancer is nourishing them — lactate and deuterium-depleted protons — providing what their damaged mitochondria need to recover. Seneff notes the same lactate and low pH environment also signals immune cells to stand down — suppressing activation and allowing the tumor to survive in the process. Once the immune cells recover, they turn on the tumor and clear it. When deuterium levels drop low enough — the cancer cell's job is done. It undergoes apoptosis. Gabor Somlyai, Hungarian biochemist and cancer researcher showed that when cancer cells are placed in deuterium-depleted water, they stop multiplying and undergo apoptosis. In high-deuterium water — they thrive. He documented patients rejected by mainstream oncology — told to go home and die. They began drinking deuterium-depleted water. Some lived far beyond predicted life expectancy. Some achieved complete recovery. This also might explain why the ketogenic diet works against cancer. Animal fats are the lowest deuterium macronutrient. A ketogenic state naturally lowers systemic deuterium intake. Combined with glucose restriction — cancer cells depend heavily on glucose to run glycolysis — both mechanisms rest on the same biology. Thomas Seyfried, Professor of Biology at Boston College, reached the conclusion that cancer is a mitochondrial metabolic disease, not a genetic one. Seneff goes one step further: deuterium overload is why the mitochondria malfunction in the first place. According to her, cancer isn't a random malfunction. It's a coordinated biological response to a systemic deuterium overload.

no.mind

190,791 Aufrufe • vor 3 Monaten

A paradigm shift is urgently needed in oncology. Conventional wisdom views radiation as a localized tool, but emerging evidence reveals its profound capacity to systemically PROMOTE cancer metastasis. In a powerful summary, Dr. Nathan Goodyear outlines the mechanisms by which radiation can inadvertently fuel the spread of cancer: - Increases Circulating Tumor Cells (CTCs): Radiation can dislodge cells from the primary tumor, releasing them into circulation as seeds for future, distant tumors. - Damages the Tumor Microenvironment: Through the "bystander effect," radiation damages healthy cells, alters epigenetics, disrupts the extracellular matrix, and modifies the local immune landscape. - Enhances Invasion & Angiogenesis: It upregulates the cancer's ability to invade surrounding tissues and stimulates angiogenesis—building the very blood vessel "highways" that facilitate spread. - Subverts the Immune System: Radiation can polarize macrophages toward the pro-tumor M2 phenotype, creating a state of chronic inflammation that allows cancer cells to evade immune detection. - Activates Dormant Sites: Via the "concomitant theory," radiation can activate distant, dormant micro-metastases, awakening sleeping giants. - Forces Mutations & Stem Cell Transformation: The genomic instability caused by radiation forces phenotypic shifts, promotes cancer stem cell transformation, and drives oncogenic metabolic shifts like the Warburg Effect. This is not to dismiss radiation's role, but to demand a more sophisticated understanding of its systemic consequences. Treatment must consider these pro-metastatic risks to truly advance patient outcomes.

A paradigm shift is urgently needed in oncology. Conventional wisdom views radiation as a localized tool, but emerging evidence reveals its profound capacity to systemically PROMOTE cancer metastasis. In a powerful summary, Dr. Nathan Goodyear outlines the mechanisms by which radiation can inadvertently fuel the spread of cancer: - Increases Circulating Tumor Cells (CTCs): Radiation can dislodge cells from the primary tumor, releasing them into circulation as seeds for future, distant tumors. - Damages the Tumor Microenvironment: Through the "bystander effect," radiation damages healthy cells, alters epigenetics, disrupts the extracellular matrix, and modifies the local immune landscape. - Enhances Invasion & Angiogenesis: It upregulates the cancer's ability to invade surrounding tissues and stimulates angiogenesis—building the very blood vessel "highways" that facilitate spread. - Subverts the Immune System: Radiation can polarize macrophages toward the pro-tumor M2 phenotype, creating a state of chronic inflammation that allows cancer cells to evade immune detection. - Activates Dormant Sites: Via the "concomitant theory," radiation can activate distant, dormant micro-metastases, awakening sleeping giants. - Forces Mutations & Stem Cell Transformation: The genomic instability caused by radiation forces phenotypic shifts, promotes cancer stem cell transformation, and drives oncogenic metabolic shifts like the Warburg Effect. This is not to dismiss radiation's role, but to demand a more sophisticated understanding of its systemic consequences. Treatment must consider these pro-metastatic risks to truly advance patient outcomes.

Camus

22,773 Aufrufe • vor 9 Monaten

Dr. Ryan Cole Issues Grave Warning: Mechanistic Link Between mRNA Vaccines and Cancer Formation Explained The alarming rise in aggressive cancers post-pandemic is no longer a mere statistical anomaly. It is a phenomenon with a plausible biological explanation, rooted in the fundamental mechanics of the immune system and the unique properties of mRNA COVID-19 vaccines. According to renowned clinical pathologist and immunologist, Dr. Ryan Cole, the issue is not one of simple coincidence but of direct mechanistic interference. The body’s sophisticated defense network is being suppressed and reprogrammed, creating a permissive environment for the initiation and proliferation of cancerous cells. Here is a breakdown of the mechanisms at play, as explained by Dr. Cole: 1. The Suppression of the Body’s "Marines" At any given moment, the human body circulates approximately 30 billion T-cells. This army includes "killer" cells whose sole purpose is to identify and destroy pathogenic invaders and, critically, atypical or cancerous cells. These cells, along with macrophages and dendritic cells, act as a constant surveillance unit, patrolling the body to clear threats. Dr. Cole states that post-vaccination, there is a significant suppression of these critical immune cell lines. The very technology designed to evoke an immune response initially suppresses it, crippling the front-line defenses that would normally identify and eliminate pre-cancerous cells before they can form tumors. 2. The Stealth Technology: Pseudouridine and Immune Evasion The core of the issue lies in the synthetic design of the mRNA shot. Natural mRNA is quickly recognized and broken down by the body. To circumvent this, vaccine manufacturers modified the RNA code by incorporating pseudouridine. "This is not natural," Dr. Cole emphasizes. "This synthetic sequence is packaged in a lipid nanoparticle and deliberately engineered to evade the immune system. Your body doesn't immediately recognize it as a threat, which is a form of initial immune suppression." This evasion allows the synthetic mRNA to hijack the body's own cells, turning them into factories that mass-produce the SARS-CoV-2 spike protein. 3. Persistent Antigen Production and Circulating Spike Unlike natural mRNA, which degrades in minutes to hours, peer-reviewed research from institutions like Stanford University (Dr. Röltgen et al.) has demonstrated that the synthetic mRNA from vaccines persists in lymph nodes for at least 60 days. The duration beyond that is unknown, as studies stopped there. This means the body is forced to continuously produce the spike protein for an extended, unnatural period. Furthermore, the spike protein does not remain localized; it cleaves off from the cells and enters systemic circulation, creating a constant state of inflammatory stress and immune activation. 4. The Critical Downregulation of Toll-like Receptors (TLRs) Perhaps one of the most concerning mechanisms is the impact on the body's signaling system. Toll-like Receptors (TLRs) are like the "toll roads" of the immune system—they are pattern recognition receptors that alert the body to different types of threats and orchestrate the appropriate defensive response. Citing a pivotal study from the Netherlands by Dr. Fassa, Dr. Cole highlights that the mRNA vaccine leads to the downregulation of key TLRs, specifically numbers 3, 4, 7, and 8. "This is devastating," he explains. "TLRs 7 and 8 are crucial for antiviral defense. But the suppression of TLRs 3 and 4 is directly associated with cancer pathogenesis. When you see a dropout of these receptors, you see a loss of immune surveillance against tumors." Aggressive breast cancers, prostate cancers, and leukemias are frequently found to have downregulated these specific Toll-like receptors. The vaccine appears to be inducing a biological state that mimics the immunosuppressed environment seen in these cancers. 5. Additional Pathways to Mutagenesis The cascade of dysfunction does not end there. The pseudouridine modification has also been shown to disrupt vital cellular communication pathways, including: - Protein Kinase Pathways: Essential for regulating cell growth, division, and survival. - Retinoic Acid Receptor Pathways: Critical for cell differentiation and apoptosis (programmed cell death). Disruption in these pathways can lead to uncontrolled cell proliferation and impaired ability to clear damaged cells—hallmarks of cancer initiation. Conclusion: A Perfect Storm for Oncogenesis Dr. Ryan Cole concludes that we are witnessing a "perfect storm" created by these interventions. The synthetic mRNA and lipid nanoparticles trigger a multi-faceted assault on immune competence: - Suppression of killer T-cells and natural killer cells. - Persistent production of an inflammatory antigen (spike protein). - Downregulation of critical cancer-fighting Toll-like Receptors. - Disruption of core cellular signaling and regulatory pathways. The result is a body less capable of performing its constant, natural duty of cancer surveillance and destruction. This is not speculation; it is a mechanistic explanation based on emerging science for the troubling oncological trends being observed globally. The claim demands urgent, independent investigation free from political or commercial influence.

Dr. Ryan Cole Issues Grave Warning: Mechanistic Link Between mRNA Vaccines and Cancer Formation Explained The alarming rise in aggressive cancers post-pandemic is no longer a mere statistical anomaly. It is a phenomenon with a plausible biological explanation, rooted in the fundamental mechanics of the immune system and the unique properties of mRNA COVID-19 vaccines. According to renowned clinical pathologist and immunologist, Dr. Ryan Cole, the issue is not one of simple coincidence but of direct mechanistic interference. The body’s sophisticated defense network is being suppressed and reprogrammed, creating a permissive environment for the initiation and proliferation of cancerous cells. Here is a breakdown of the mechanisms at play, as explained by Dr. Cole: 1. The Suppression of the Body’s "Marines" At any given moment, the human body circulates approximately 30 billion T-cells. This army includes "killer" cells whose sole purpose is to identify and destroy pathogenic invaders and, critically, atypical or cancerous cells. These cells, along with macrophages and dendritic cells, act as a constant surveillance unit, patrolling the body to clear threats. Dr. Cole states that post-vaccination, there is a significant suppression of these critical immune cell lines. The very technology designed to evoke an immune response initially suppresses it, crippling the front-line defenses that would normally identify and eliminate pre-cancerous cells before they can form tumors. 2. The Stealth Technology: Pseudouridine and Immune Evasion The core of the issue lies in the synthetic design of the mRNA shot. Natural mRNA is quickly recognized and broken down by the body. To circumvent this, vaccine manufacturers modified the RNA code by incorporating pseudouridine. "This is not natural," Dr. Cole emphasizes. "This synthetic sequence is packaged in a lipid nanoparticle and deliberately engineered to evade the immune system. Your body doesn't immediately recognize it as a threat, which is a form of initial immune suppression." This evasion allows the synthetic mRNA to hijack the body's own cells, turning them into factories that mass-produce the SARS-CoV-2 spike protein. 3. Persistent Antigen Production and Circulating Spike Unlike natural mRNA, which degrades in minutes to hours, peer-reviewed research from institutions like Stanford University (Dr. Röltgen et al.) has demonstrated that the synthetic mRNA from vaccines persists in lymph nodes for at least 60 days. The duration beyond that is unknown, as studies stopped there. This means the body is forced to continuously produce the spike protein for an extended, unnatural period. Furthermore, the spike protein does not remain localized; it cleaves off from the cells and enters systemic circulation, creating a constant state of inflammatory stress and immune activation. 4. The Critical Downregulation of Toll-like Receptors (TLRs) Perhaps one of the most concerning mechanisms is the impact on the body's signaling system. Toll-like Receptors (TLRs) are like the "toll roads" of the immune system—they are pattern recognition receptors that alert the body to different types of threats and orchestrate the appropriate defensive response. Citing a pivotal study from the Netherlands by Dr. Fassa, Dr. Cole highlights that the mRNA vaccine leads to the downregulation of key TLRs, specifically numbers 3, 4, 7, and 8. "This is devastating," he explains. "TLRs 7 and 8 are crucial for antiviral defense. But the suppression of TLRs 3 and 4 is directly associated with cancer pathogenesis. When you see a dropout of these receptors, you see a loss of immune surveillance against tumors." Aggressive breast cancers, prostate cancers, and leukemias are frequently found to have downregulated these specific Toll-like receptors. The vaccine appears to be inducing a biological state that mimics the immunosuppressed environment seen in these cancers. 5. Additional Pathways to Mutagenesis The cascade of dysfunction does not end there. The pseudouridine modification has also been shown to disrupt vital cellular communication pathways, including: - Protein Kinase Pathways: Essential for regulating cell growth, division, and survival. - Retinoic Acid Receptor Pathways: Critical for cell differentiation and apoptosis (programmed cell death). Disruption in these pathways can lead to uncontrolled cell proliferation and impaired ability to clear damaged cells—hallmarks of cancer initiation. Conclusion: A Perfect Storm for Oncogenesis Dr. Ryan Cole concludes that we are witnessing a "perfect storm" created by these interventions. The synthetic mRNA and lipid nanoparticles trigger a multi-faceted assault on immune competence: - Suppression of killer T-cells and natural killer cells. - Persistent production of an inflammatory antigen (spike protein). - Downregulation of critical cancer-fighting Toll-like Receptors. - Disruption of core cellular signaling and regulatory pathways. The result is a body less capable of performing its constant, natural duty of cancer surveillance and destruction. This is not speculation; it is a mechanistic explanation based on emerging science for the troubling oncological trends being observed globally. The claim demands urgent, independent investigation free from political or commercial influence.

Camus

67,994 Aufrufe • vor 11 Monaten

Ivermectin and Mebendazole in Cancer Patients The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Overall, it is estimated that annual costs of standard chemotherapies average $111,000 per year. Background: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol. Methods: Prospective observational cohort of 197 cancer patients, who were prescribed ivermectin and mebendazole off-label through telemedicine (platform by licensed U.S. healthcare providers) Participants received compounded oral capsules containing 25 mg ivermectin and 250 mg mebendazole. Data were collected via voluntary, standardized digital surveys at baseline and at approximately 6-month follow-up. Of the initial cohort (N = 197), baseline characteristics, including cancer type and disease status, were assessed. A total of 122 participants completed the follow-up survey (61.9% response rate) Results: Mean age of 67 years, (52.3% male, 47.7% female). Cancer types included Prostate 27.9% Breast 18.3% Lung 8.6% Colon 5.1% Urologic 4.6% Pancreatic 3.0% Liver 2.5% Gynaecologic 2.5% Hematologic 2.5% Median duration since initial diagnosis, 1.2 years 37.1% experiencing active disease progression. 6-month follow-up Medication adherence, 86.9% Full initial 90-capsule ivermectin-mebendazole prescription. The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Notably, 48.4% of cohort, strongest positive outcomes: Regression, 15.6% No current evidence of disease (NED), 32.8% Disease stability, 36.1% Disease progression, 15.6% No significant dose-response association was observed for cancer outcomes (p = 0.91), without a clear dose-response gradient for efficacy. Side effects Mild side effects (primarily gastrointestinal), 25.4% (93.6% of those affected continued treatment through minor dose adjustments) Concurrent conventional therapies Chemotherapy, 27.9% Radiation therapy, 21.3% Surgery, 19.7% Adjunctive interventions such as supplement use, 49.2% Dietary modification, 37.7% Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials Validate these observations and further define optimal dosing strategies. Mechanism (pharmacodynamics) Ivermectin and mebendazole are antiparasitic agents, demonstrated highly promising anti-cancer activity. Ivermectin Shown to exert over 14 distinct anti-cancer mechanisms across more than 12 cancer types, inhibiting cancer cell proliferation, metastasis, angiogenesis, mitochondrial function. Has demonstrated excellent safety in cancer patients (including those actively undergoing chemotherapy) Ivermectin and mebendazole selectively target cancer stem cells Mebendazole Microtubule disruption, leading to effective cell cycle arrest Potent induction of apoptosis Significant inhibition of tumour growth Inhibition of angiogenesis Disruption of glucose uptake When used together Target non-overlapping pathways, resulting in synergistic tumour regression, cancer stem cell depletion, and reversal of multidrug resistance in multiple in vitro and in vivo models Biodistribution, ivermectin and mebendazole document excellent tissue penetration

Ivermectin and Mebendazole in Cancer Patients The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Overall, it is estimated that annual costs of standard chemotherapies average $111,000 per year. Background: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole have demonstrated multi-target anti-cancer activity. This paper evaluates real-world patient-reported outcomes, safety, and adherence in a cohort of cancer patients utilizing this combination protocol. Methods: Prospective observational cohort of 197 cancer patients, who were prescribed ivermectin and mebendazole off-label through telemedicine (platform by licensed U.S. healthcare providers) Participants received compounded oral capsules containing 25 mg ivermectin and 250 mg mebendazole. Data were collected via voluntary, standardized digital surveys at baseline and at approximately 6-month follow-up. Of the initial cohort (N = 197), baseline characteristics, including cancer type and disease status, were assessed. A total of 122 participants completed the follow-up survey (61.9% response rate) Results: Mean age of 67 years, (52.3% male, 47.7% female). Cancer types included Prostate 27.9% Breast 18.3% Lung 8.6% Colon 5.1% Urologic 4.6% Pancreatic 3.0% Liver 2.5% Gynaecologic 2.5% Hematologic 2.5% Median duration since initial diagnosis, 1.2 years 37.1% experiencing active disease progression. 6-month follow-up Medication adherence, 86.9% Full initial 90-capsule ivermectin-mebendazole prescription. The Clinical Benefit Ratio Complete Response + Partial Response + Stable Disease / Total Patients (CBR) was 84.4% Notably, 48.4% of cohort, strongest positive outcomes: Regression, 15.6% No current evidence of disease (NED), 32.8% Disease stability, 36.1% Disease progression, 15.6% No significant dose-response association was observed for cancer outcomes (p = 0.91), without a clear dose-response gradient for efficacy. Side effects Mild side effects (primarily gastrointestinal), 25.4% (93.6% of those affected continued treatment through minor dose adjustments) Concurrent conventional therapies Chemotherapy, 27.9% Radiation therapy, 21.3% Surgery, 19.7% Adjunctive interventions such as supplement use, 49.2% Dietary modification, 37.7% Conclusions: In this prospective real-world cohort, the combination of ivermectin and mebendazole was associated with high rates of self-reported clinical benefit, with nearly half of participants reporting tumours regression or no current evidence of disease across a heterogeneous population of cancer patients. These findings provide a compelling clinical signal that these well-tolerated, repurposed agents may offer therapeutic benefit. However, observational design, reliance on self-reported outcomes, and potential for selection bias and uncontrolled confounding, these findings should be interpreted as hypothesis-generating. Urgent prospective, randomized, placebo-controlled clinical trials Validate these observations and further define optimal dosing strategies. Mechanism (pharmacodynamics) Ivermectin and mebendazole are antiparasitic agents, demonstrated highly promising anti-cancer activity. Ivermectin Shown to exert over 14 distinct anti-cancer mechanisms across more than 12 cancer types, inhibiting cancer cell proliferation, metastasis, angiogenesis, mitochondrial function. Has demonstrated excellent safety in cancer patients (including those actively undergoing chemotherapy) Ivermectin and mebendazole selectively target cancer stem cells Mebendazole Microtubule disruption, leading to effective cell cycle arrest Potent induction of apoptosis Significant inhibition of tumour growth Inhibition of angiogenesis Disruption of glucose uptake When used together Target non-overlapping pathways, resulting in synergistic tumour regression, cancer stem cell depletion, and reversal of multidrug resistance in multiple in vitro and in vivo models Biodistribution, ivermectin and mebendazole document excellent tissue penetration

Dr. Zakaria MD

10,766 Aufrufe • vor 1 Monat

Can people in power/ authority kindly stop with this absolute BS on "fasting killing cancer cells" and citing religious nonsense to appeal to peoples emotions? Fasting is really quite dangerous for cancer patients in real life. Let me explain and bury this myth once and for all, especially for science illiterates like this guy. [1] The most common argument is that fasting "starves" cancer by cutting off its sugar (glucose) supply. While it is true that cancer cells consume vast amounts of glucose, they are biologically aggressive survivalists. If you stop eating, your body eventually switches to burning fat and breaking down muscle for energy. Cancer cells are highly adaptable; when glucose is low, many types of cancer can mutate to feed on other fuel sources, such as lactate, amino acids (from your muscles), or fatty acids. You cannot simply "starve" a tumor without starving the patient first. [2] Fasting is dangerous for cancer patients because of cancer cachexia - a wasting syndrome where the body loses muscle and fat rapidly. Cachexia is responsible for up to 30% of cancer deaths. Cancer puts the body in a hyper-metabolic state (burning energy fast). If a patient fasts, they risk accelerating muscle loss and weakening their immune system. A weak body cannot tolerate life-saving treatments like chemotherapy or radiation, nor can it fight off infections. [3] Most claims about fasting curing cancer come from studies on mice or cells in a petri dish. In a dish: You can kill cancer cells with almost anything (lemon juice, bleach, starvation, even shooting a bullet at it at close point or using a grenade to destroy the entire lab) because they have no immune system or body to protect them. In a human: The biology is infinitely more complex. Human metabolism, hormonal fluctuations, and tumor micro-environments mean that what shrinks a tumor in a mouse often fails completely in human trials. [4] Proponents often cite "autophagy" (the body's cellular recycling process triggered by fasting) as the cure. They claim it cleans out cancerous cells. Science shows that autophagy is a double-edged sword. -In all people, autophagy is a normal physiological process - whether fasting or not, which help in cleaning up damaged cells. -But in patients with cancer, once a tumor exists, cancer cells can actually hijack autophagy to survive stress (like chemotherapy) and repair themselves. In this context, fasting could theoretically help the cancer survive the treatment intended to kill it. [5] "Cancer" is not one disease; it is over 200 different diseases characterized by uncontrolled cell growth. Some cancers are driven by hormones, some by genetic mutations, and some by viruses. A fasting protocol that slows down one specific type of breast cancer might have zero effect on pancreatic cancer, or worse, accelerate a different type. The most lethal aspect of this misinformation is the delay in treatment. Cancer is a time-sensitive disease. While a patient spends months trying to fast the cancer away based on religious or alternative advice, the cancer often metastasizes (spreads) to other organs. Once cancer spreads, it often moves from being curable to being terminal. Relying solely on fasting wastes the critical window where medical intervention could have saved a life. Suggesting a single "ancient cure" for 200 complex genetic diseases is scientifically illogical... ...and generally stupid, as this video proves.

Can people in power/ authority kindly stop with this absolute BS on "fasting killing cancer cells" and citing religious nonsense to appeal to peoples emotions? Fasting is really quite dangerous for cancer patients in real life. Let me explain and bury this myth once and for all, especially for science illiterates like this guy. [1] The most common argument is that fasting "starves" cancer by cutting off its sugar (glucose) supply. While it is true that cancer cells consume vast amounts of glucose, they are biologically aggressive survivalists. If you stop eating, your body eventually switches to burning fat and breaking down muscle for energy. Cancer cells are highly adaptable; when glucose is low, many types of cancer can mutate to feed on other fuel sources, such as lactate, amino acids (from your muscles), or fatty acids. You cannot simply "starve" a tumor without starving the patient first. [2] Fasting is dangerous for cancer patients because of cancer cachexia - a wasting syndrome where the body loses muscle and fat rapidly. Cachexia is responsible for up to 30% of cancer deaths. Cancer puts the body in a hyper-metabolic state (burning energy fast). If a patient fasts, they risk accelerating muscle loss and weakening their immune system. A weak body cannot tolerate life-saving treatments like chemotherapy or radiation, nor can it fight off infections. [3] Most claims about fasting curing cancer come from studies on mice or cells in a petri dish. In a dish: You can kill cancer cells with almost anything (lemon juice, bleach, starvation, even shooting a bullet at it at close point or using a grenade to destroy the entire lab) because they have no immune system or body to protect them. In a human: The biology is infinitely more complex. Human metabolism, hormonal fluctuations, and tumor micro-environments mean that what shrinks a tumor in a mouse often fails completely in human trials. [4] Proponents often cite "autophagy" (the body's cellular recycling process triggered by fasting) as the cure. They claim it cleans out cancerous cells. Science shows that autophagy is a double-edged sword. -In all people, autophagy is a normal physiological process - whether fasting or not, which help in cleaning up damaged cells. -But in patients with cancer, once a tumor exists, cancer cells can actually hijack autophagy to survive stress (like chemotherapy) and repair themselves. In this context, fasting could theoretically help the cancer survive the treatment intended to kill it. [5] "Cancer" is not one disease; it is over 200 different diseases characterized by uncontrolled cell growth. Some cancers are driven by hormones, some by genetic mutations, and some by viruses. A fasting protocol that slows down one specific type of breast cancer might have zero effect on pancreatic cancer, or worse, accelerate a different type. The most lethal aspect of this misinformation is the delay in treatment. Cancer is a time-sensitive disease. While a patient spends months trying to fast the cancer away based on religious or alternative advice, the cancer often metastasizes (spreads) to other organs. Once cancer spreads, it often moves from being curable to being terminal. Relying solely on fasting wastes the critical window where medical intervention could have saved a life. Suggesting a single "ancient cure" for 200 complex genetic diseases is scientifically illogical... ...and generally stupid, as this video proves.

TheLiverDoc™

193,282 Aufrufe • vor 6 Monaten

The Dangerous Cult of 'Fasting' Influencers. Fasting has its anecdotal benefits, yes. But it is overrated. And water fasting is highly overrated. But this video featuring a Cardiologist is amusingly nonsense. There is no study from Boston (from a "University?" - how vague!) that says 7-days water fasting reduces risk of cancer (what cancer?) by 70%. And there is no proof that fasting kills cancer cells in humans. Here is what fasting does to cancers in humans. Nothing. Fasting is now become a sort of religion-like cult for wellness influencers to rake in views and engagement. From a scientific standpoint, there are no realistically good human studies to prove anything from fasting that benefits cancers. I know, I know, "autophagy" and all that. Autophagy: Autophagy is the natural, conserved degradation of the cell that removes unnecessary or dysfunctional components. Yes, its a legit term and all. But in the context of cancer reduction and fasting in humans, it sounds like "immunity boosting," another wellness fraud term. The effects of fasting on cancer cells are all based on MOUSE studies, and none explicitly translated to humans. See this paper: everything is based on cells and tissues and small animal experiments: "While research on the subject is tantalizing, there’s little clinical evidence involving humans to substantiate the claims. Studies on the potential impacts on cancer treatment from various forms of fasting or calorie restriction, including the possibility that they reduce side effects, have been limited." "Fasting may not be appropriate for malnourished individuals or those with cancer cachexia, which results in a continuing loss of skeletal muscle mass, or for people with chronic diseases. Those with diabetes need to be very careful, because of the risk of hypoglycemia." "Based on our systematic review and meta-analysis, there is currently no evidence supporting the superiority of therapeutic fasting over non-fasting in preventing chemotherapy toxicity." - see here: Even intermittent fasting (IF) is overrated in cancer. "IF may be considered in adults seeking cancer-prevention benefits through means of weight management, butwhether IF itself affects cancer-related metabolic and molecular pathways remains unanswered. See here: Also this: "Fasting for short periods does not have any beneficial effect on the quality of life of cancer patients during treatment. Evidence on fasting regimes reducing side effects and toxicities of chemotherapy is missing." See here: The whole aspect of "fasting reducing cancer incidence" in the real world is just due to weight loss. Obesity is associated with at least 13 types of cancers and reversing obesity reduces risk of cancer - nothing to do with fasting killing off cancers cells in the body. And one can lose weight even without fasting. See here: Everything from prevention of adverse events of cancer, to reduction in side effects from chemotherapy, to slowing cancer growth by reducing glucose levels, to promoting cell regeneration by affecting autophagy is all LAB BASED MOLECULAR LEVEL HYPOTHESIS that has not been proven conclusively in humans. See here: Cancer patients must not starve. They must remain hydrated and they must eat a well balanced diet because cancer condition is highly demanding. And dont water fast for 7 days. Easy for people to make reels on it, but in real life, it may prove disastrous. Water fast does make you lose weight (because of starvation) but it is not at all a healthy way to lose weight. Stop with this fasting and cancer madness already.

The Dangerous Cult of 'Fasting' Influencers. Fasting has its anecdotal benefits, yes. But it is overrated. And water fasting is highly overrated. But this video featuring a Cardiologist is amusingly nonsense. There is no study from Boston (from a "University?" - how vague!) that says 7-days water fasting reduces risk of cancer (what cancer?) by 70%. And there is no proof that fasting kills cancer cells in humans. Here is what fasting does to cancers in humans. Nothing. Fasting is now become a sort of religion-like cult for wellness influencers to rake in views and engagement. From a scientific standpoint, there are no realistically good human studies to prove anything from fasting that benefits cancers. I know, I know, "autophagy" and all that. Autophagy: Autophagy is the natural, conserved degradation of the cell that removes unnecessary or dysfunctional components. Yes, its a legit term and all. But in the context of cancer reduction and fasting in humans, it sounds like "immunity boosting," another wellness fraud term. The effects of fasting on cancer cells are all based on MOUSE studies, and none explicitly translated to humans. See this paper: everything is based on cells and tissues and small animal experiments: "While research on the subject is tantalizing, there’s little clinical evidence involving humans to substantiate the claims. Studies on the potential impacts on cancer treatment from various forms of fasting or calorie restriction, including the possibility that they reduce side effects, have been limited." "Fasting may not be appropriate for malnourished individuals or those with cancer cachexia, which results in a continuing loss of skeletal muscle mass, or for people with chronic diseases. Those with diabetes need to be very careful, because of the risk of hypoglycemia." "Based on our systematic review and meta-analysis, there is currently no evidence supporting the superiority of therapeutic fasting over non-fasting in preventing chemotherapy toxicity." - see here: Even intermittent fasting (IF) is overrated in cancer. "IF may be considered in adults seeking cancer-prevention benefits through means of weight management, butwhether IF itself affects cancer-related metabolic and molecular pathways remains unanswered. See here: Also this: "Fasting for short periods does not have any beneficial effect on the quality of life of cancer patients during treatment. Evidence on fasting regimes reducing side effects and toxicities of chemotherapy is missing." See here: The whole aspect of "fasting reducing cancer incidence" in the real world is just due to weight loss. Obesity is associated with at least 13 types of cancers and reversing obesity reduces risk of cancer - nothing to do with fasting killing off cancers cells in the body. And one can lose weight even without fasting. See here: Everything from prevention of adverse events of cancer, to reduction in side effects from chemotherapy, to slowing cancer growth by reducing glucose levels, to promoting cell regeneration by affecting autophagy is all LAB BASED MOLECULAR LEVEL HYPOTHESIS that has not been proven conclusively in humans. See here: Cancer patients must not starve. They must remain hydrated and they must eat a well balanced diet because cancer condition is highly demanding. And dont water fast for 7 days. Easy for people to make reels on it, but in real life, it may prove disastrous. Water fast does make you lose weight (because of starvation) but it is not at all a healthy way to lose weight. Stop with this fasting and cancer madness already.

TheLiverDoc™

269,476 Aufrufe • vor 2 Jahren

Breaking New Ground in Glioblastoma Treatment: Insights from Dr. Patrick Soon-Shiong and Dr. Simon Khagi Glioblastoma (GBM) and pancreatic cancer remain two of the most formidable challenges in oncology, with survival rates stubbornly low despite decades of research. Dr. Patrick Soon-Shiong, a pioneering immunotherapist and founder of ImmunityBio, and Dr. Simon Khagi, Medical Director of Neuro-Oncology at Hoag Memorial Hospital Presbyterian, are tackling these deadly diseases head-on with innovative approaches that challenge conventional treatments. Their recent discussion, centered on reimagining first- and second-line therapies for GBM, highlights a bold shift toward harnessing the immune system—specifically natural killer (NK) cells—to fight cancer. The standard first-line therapy for GBM, known as the Stupp protocol, was established in 2005 by Dr. Roger Stupp. It involves maximal surgical resection, followed by radiation and chemotherapy with temozolomide (Temodar). While this approach offers some benefit, Dr. Soon-Shiong questions its logic, pointing out that radiation, anesthesia, temozolomide, and steroids—often used to manage brain swelling—severely deplete the body’s NK cells, critical immune defenders against cancer. “What is the logic of winning the battle and losing the war?” he asks, emphasizing how these treatments may undermine the body’s natural defenses, leaving patients vulnerable to recurrence. Dr. Khagi, leading a clinical trial at Hoag, is exploring an alternative: leveraging engineered NK cells and interleukin-15 (IL-15) stimulation to target GBM without the collateral damage of traditional therapies. The trial, which builds on Dr. Soon-Shiong’s work at ImmunityBio, involves infusing patients with “off-the-shelf” NK cells—lymphocytes engineered to aggressively target tumor cells—and an IL-15-based drug (N-803, or Anktiva) to activate the patient’s immune system. These cells are produced by isolating lymphocytes, modifying them to enhance their cancer-killing ability, and freezing them in billions for intravenous infusion. Unlike chemotherapy, this approach aims to cross the blood-brain barrier and attack GBM cells directly. At Hoag, Dr. Khagi has treated eight patients with recurrent GBM using this regimen, combining NK cells and N-803 with bevacizumab (Avastin), a standard second-line antibody drug. Early results are promising. One patient, treated with two cycles of the NK cell/IL-15/bevacizumab combination, showed a remarkable response. An MRI taken two months apart revealed a significant reduction in tumor size, with the brain’s anatomy returning to its natural structure. “The bulkiness, that dense area of white, essentially melted away,” Dr. Khagi explains, noting the tumor’s irregular, aggressive appearance was replaced by a normalized brain architecture. This patient’s response was enhanced by a unique addition: the Optune device, a wearable FDA-approved system that delivers tumor-treating fields (TTFields) via arrays placed on the scalp. These arrays generate alternating electric fields that disrupt cancer cell division. Dr. Khagi, who co-authored a 2025 paper on TTFields in The Oncologist, highlights how Optune not only kills cancer cells but also alters the tumor microenvironment, making it more receptive to NK cell therapy. “The mechanism of cell death and its impact on the tumor microenvironment is profound,” he says, suggesting synergy between Optune and the NK cell/IL-15 approach. Dr. Soon-Shiong emphasizes the broader implications: “If we can break the back of glioblastoma and pancreatic cancer, it opens up the field in terms of the skeptics.” He envisions a future where immune-based therapies replace the toxic, immune-suppressing treatments that dominate current protocols. By focusing on absolute lymphocyte counts—a measure of immune health—Dr. Khagi and Dr. Soon-Shiong are redefining success in GBM treatment, prioritizing long-term immune activation over short-term tumor reduction. The trial at Hoag is still in its early stages, but the results are encouraging. One patient treated outside the current study has survived four years post-second-line therapy, a rare outcome in GBM. Dr. Khagi’s patient, a “true pioneer,” continues to inspire, with plans to share his experience directly. These advancements, combining cutting-edge immunotherapy with technologies like Optune, signal a potential paradigm shift in treating one of cancer’s toughest foes.

Breaking New Ground in Glioblastoma Treatment: Insights from Dr. Patrick Soon-Shiong and Dr. Simon Khagi Glioblastoma (GBM) and pancreatic cancer remain two of the most formidable challenges in oncology, with survival rates stubbornly low despite decades of research. Dr. Patrick Soon-Shiong, a pioneering immunotherapist and founder of ImmunityBio, and Dr. Simon Khagi, Medical Director of Neuro-Oncology at Hoag Memorial Hospital Presbyterian, are tackling these deadly diseases head-on with innovative approaches that challenge conventional treatments. Their recent discussion, centered on reimagining first- and second-line therapies for GBM, highlights a bold shift toward harnessing the immune system—specifically natural killer (NK) cells—to fight cancer. The standard first-line therapy for GBM, known as the Stupp protocol, was established in 2005 by Dr. Roger Stupp. It involves maximal surgical resection, followed by radiation and chemotherapy with temozolomide (Temodar). While this approach offers some benefit, Dr. Soon-Shiong questions its logic, pointing out that radiation, anesthesia, temozolomide, and steroids—often used to manage brain swelling—severely deplete the body’s NK cells, critical immune defenders against cancer. “What is the logic of winning the battle and losing the war?” he asks, emphasizing how these treatments may undermine the body’s natural defenses, leaving patients vulnerable to recurrence. Dr. Khagi, leading a clinical trial at Hoag, is exploring an alternative: leveraging engineered NK cells and interleukin-15 (IL-15) stimulation to target GBM without the collateral damage of traditional therapies. The trial, which builds on Dr. Soon-Shiong’s work at ImmunityBio, involves infusing patients with “off-the-shelf” NK cells—lymphocytes engineered to aggressively target tumor cells—and an IL-15-based drug (N-803, or Anktiva) to activate the patient’s immune system. These cells are produced by isolating lymphocytes, modifying them to enhance their cancer-killing ability, and freezing them in billions for intravenous infusion. Unlike chemotherapy, this approach aims to cross the blood-brain barrier and attack GBM cells directly. At Hoag, Dr. Khagi has treated eight patients with recurrent GBM using this regimen, combining NK cells and N-803 with bevacizumab (Avastin), a standard second-line antibody drug. Early results are promising. One patient, treated with two cycles of the NK cell/IL-15/bevacizumab combination, showed a remarkable response. An MRI taken two months apart revealed a significant reduction in tumor size, with the brain’s anatomy returning to its natural structure. “The bulkiness, that dense area of white, essentially melted away,” Dr. Khagi explains, noting the tumor’s irregular, aggressive appearance was replaced by a normalized brain architecture. This patient’s response was enhanced by a unique addition: the Optune device, a wearable FDA-approved system that delivers tumor-treating fields (TTFields) via arrays placed on the scalp. These arrays generate alternating electric fields that disrupt cancer cell division. Dr. Khagi, who co-authored a 2025 paper on TTFields in The Oncologist, highlights how Optune not only kills cancer cells but also alters the tumor microenvironment, making it more receptive to NK cell therapy. “The mechanism of cell death and its impact on the tumor microenvironment is profound,” he says, suggesting synergy between Optune and the NK cell/IL-15 approach. Dr. Soon-Shiong emphasizes the broader implications: “If we can break the back of glioblastoma and pancreatic cancer, it opens up the field in terms of the skeptics.” He envisions a future where immune-based therapies replace the toxic, immune-suppressing treatments that dominate current protocols. By focusing on absolute lymphocyte counts—a measure of immune health—Dr. Khagi and Dr. Soon-Shiong are redefining success in GBM treatment, prioritizing long-term immune activation over short-term tumor reduction. The trial at Hoag is still in its early stages, but the results are encouraging. One patient treated outside the current study has survived four years post-second-line therapy, a rare outcome in GBM. Dr. Khagi’s patient, a “true pioneer,” continues to inspire, with plans to share his experience directly. These advancements, combining cutting-edge immunotherapy with technologies like Optune, signal a potential paradigm shift in treating one of cancer’s toughest foes.

Camus

32,585 Aufrufe • vor 1 Jahr

"Chemotherapy Is A Hoax & A Scam Perpetuated By Big Pharma To Make Money At The Expense Of People Who Suffer." Dr Paul Marik, MD "Chemotherapy Doesn't Save Lives, It Reduces Life....But It Generates Billions Of Dollars." "Chemotherapy Causes Metastasis, It Spreads Cancer." "Chemotherapy Prolongs Life 2-3 Months, That's The Sum Benefit." "For some Cancers, such as gastric cancer, chemotherapy actually reduces life expectancy." "It also activates cancer stem cells. Chemotherapy is the worst thing possible that you would want." "These chemotherapy drugs cost patients over $100,000 a year & 50-60% of patients with cancer face financial ruin because of the cost of their medication." Cancer is not genetic. Cancer is mitochondrial dysfunction. Metabolic Ketogenic Therapy & a targeted protocol including Ivermectin, Mebendazole, Fenbendazole, Methylene Blue & a host of other proven cancer killers is an effective 1st line therapy for the treatment of cancer. Why Is Chemotherapy So Toxic? Chemotherapy came from one of the Cruelest Weapons ever invented...Mustard Gas. In 1925, The geneva Protocol banned Mustard Gas use as a weapon of war, citing it's deadly harm as a chemical weapon. But, researchers found it destroyed bone marrow & lymphatic tissue to market as a profitable drug. The 1st chemotherapy was Mechlorethamine Hydrochloride (HN2), Nitrogen Mustard. Today, five Nitrogen Mustards are commonly used in cancer therapy, including Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan & Chlorambucil. Chemotherapy kills every cell in its path which is why administering it requires protective gear. It wipes out crucial NK T-Cells which is our bodies only natural defense by releasing Cytokines & killing infected cells. When Chemotherapy & Radiation take out our final defense in NK T-Cells, we are left without a working immune system & further damage & Cancer ensues. Cancer Can Be Prevented & Treated Using The Hybrid Cancer Protocol Linked Below: which is a 7 pronged protocol using a Ketogenic Low Carb, seed oil free, sugar free diet. Fasting, exercise, vitamins like D, Zinc & Magnesium. And Methylene Blue, Ivermectin & Fenbendazole. 👇Dr Marik & Dr Kory: Ivermectin For Cancer👇 👇Dr Marik et al: Hybrid Cancer Treatment Protocol👇 👇Dr Marik: Metabolic Cancer Treatment Book👇 Speaker: drpaulmarik Video: WR

"Chemotherapy Is A Hoax & A Scam Perpetuated By Big Pharma To Make Money At The Expense Of People Who Suffer." Dr Paul Marik, MD "Chemotherapy Doesn't Save Lives, It Reduces Life....But It Generates Billions Of Dollars." "Chemotherapy Causes Metastasis, It Spreads Cancer." "Chemotherapy Prolongs Life 2-3 Months, That's The Sum Benefit." "For some Cancers, such as gastric cancer, chemotherapy actually reduces life expectancy." "It also activates cancer stem cells. Chemotherapy is the worst thing possible that you would want." "These chemotherapy drugs cost patients over $100,000 a year & 50-60% of patients with cancer face financial ruin because of the cost of their medication." Cancer is not genetic. Cancer is mitochondrial dysfunction. Metabolic Ketogenic Therapy & a targeted protocol including Ivermectin, Mebendazole, Fenbendazole, Methylene Blue & a host of other proven cancer killers is an effective 1st line therapy for the treatment of cancer. Why Is Chemotherapy So Toxic? Chemotherapy came from one of the Cruelest Weapons ever invented...Mustard Gas. In 1925, The geneva Protocol banned Mustard Gas use as a weapon of war, citing it's deadly harm as a chemical weapon. But, researchers found it destroyed bone marrow & lymphatic tissue to market as a profitable drug. The 1st chemotherapy was Mechlorethamine Hydrochloride (HN2), Nitrogen Mustard. Today, five Nitrogen Mustards are commonly used in cancer therapy, including Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan & Chlorambucil. Chemotherapy kills every cell in its path which is why administering it requires protective gear. It wipes out crucial NK T-Cells which is our bodies only natural defense by releasing Cytokines & killing infected cells. When Chemotherapy & Radiation take out our final defense in NK T-Cells, we are left without a working immune system & further damage & Cancer ensues. Cancer Can Be Prevented & Treated Using The Hybrid Cancer Protocol Linked Below: which is a 7 pronged protocol using a Ketogenic Low Carb, seed oil free, sugar free diet. Fasting, exercise, vitamins like D, Zinc & Magnesium. And Methylene Blue, Ivermectin & Fenbendazole. 👇Dr Marik & Dr Kory: Ivermectin For Cancer👇 👇Dr Marik et al: Hybrid Cancer Treatment Protocol👇 👇Dr Marik: Metabolic Cancer Treatment Book👇 Speaker: drpaulmarik Video: WR

Valerie Anne Smith

146,787 Aufrufe • vor 1 Jahr

"Chemotherapy Is A Hoax & A Scam Perpetuated By Big Pharma To Make Money At The Expense Of People Who Suffer." Dr Paul Marik, MD "Chemotherapy Doesn't Save Lives, But It Generates Billions Of Dollars." "Chemotherapy Causes Metastasis, It Spreads Cancer." "Chemotherapy Prolongs Life 2-3 Months, That's The Sum Benefit." "For some Cancers, such as gastric cancer, chemotherapy actually reduces life expectancy." "It also activates cancer stem cells. Chemotherapy is the worst thing possible that you would want." "These chemotherapy drugs cost patients over $100,000 a year & 50-60% of patients with cancer face financial ruin because of the cost of their medication." Cancer is not genetic. Cancer is mitochondrial dysfunction. Metabolic Ketogenic Therapy & a targeted protocol including Ivermectin, Mebendazole, Fenbendazole, Methylene Blue & a host of other proven cancer killers is an effective 1st line therapy for the treatment of cancer. Why Is Chemotherapy So Toxic? Chemotherapy came from one of the Cruelest Weapons ever invented...Mustard Gas. In 1925, The geneva Protocol banned Mustard Gas use as a weapon of war, citing it's deadly harm as a chemical weapon. But, researchers found it destroyed bone marrow & lymphatic tissue to market as a profitable drug. The 1st chemotherapy was Mechlorethamine Hydrochloride (HN2), Nitrogen Mustard. Today, five Nitrogen Mustards are commonly used in cancer therapy, including Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan & Chlorambucil. Chemotherapy kills every cell in its path which is why administering it requires protective gear. It wipes out crucial NK T-Cells which is our bodies only natural defense by releasing Cytokines & killing infected cells. When Chemotherapy & Radiation take out our final defense in NK T-Cells, we are left without a working immune system & further damage & Cancer ensues. Cancer Can Be Prevented & Treated Using The Hybrid Cancer Protocol Linked Below: which is a 7 pronged protocol using a Ketogenic Low Carb, seed oil free, sugar free diet. Fasting, exercise, vitamins like D, Zinc & Magnesium. And Methylene Blue, Ivermectin & Fenbendazole. 👇Dr Marik & Dr Kory: Ivermectin For Cancer👇 👇Dr Marik et al: Hybrid Cancer Treatment Protocol👇 👇Dr Marik: Metabolic Cancer Treatment Book👇 Speaker: drpaulmarik Video: Wellness Radar

"Chemotherapy Is A Hoax & A Scam Perpetuated By Big Pharma To Make Money At The Expense Of People Who Suffer." Dr Paul Marik, MD "Chemotherapy Doesn't Save Lives, But It Generates Billions Of Dollars." "Chemotherapy Causes Metastasis, It Spreads Cancer." "Chemotherapy Prolongs Life 2-3 Months, That's The Sum Benefit." "For some Cancers, such as gastric cancer, chemotherapy actually reduces life expectancy." "It also activates cancer stem cells. Chemotherapy is the worst thing possible that you would want." "These chemotherapy drugs cost patients over $100,000 a year & 50-60% of patients with cancer face financial ruin because of the cost of their medication." Cancer is not genetic. Cancer is mitochondrial dysfunction. Metabolic Ketogenic Therapy & a targeted protocol including Ivermectin, Mebendazole, Fenbendazole, Methylene Blue & a host of other proven cancer killers is an effective 1st line therapy for the treatment of cancer. Why Is Chemotherapy So Toxic? Chemotherapy came from one of the Cruelest Weapons ever invented...Mustard Gas. In 1925, The geneva Protocol banned Mustard Gas use as a weapon of war, citing it's deadly harm as a chemical weapon. But, researchers found it destroyed bone marrow & lymphatic tissue to market as a profitable drug. The 1st chemotherapy was Mechlorethamine Hydrochloride (HN2), Nitrogen Mustard. Today, five Nitrogen Mustards are commonly used in cancer therapy, including Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan & Chlorambucil. Chemotherapy kills every cell in its path which is why administering it requires protective gear. It wipes out crucial NK T-Cells which is our bodies only natural defense by releasing Cytokines & killing infected cells. When Chemotherapy & Radiation take out our final defense in NK T-Cells, we are left without a working immune system & further damage & Cancer ensues. Cancer Can Be Prevented & Treated Using The Hybrid Cancer Protocol Linked Below: which is a 7 pronged protocol using a Ketogenic Low Carb, seed oil free, sugar free diet. Fasting, exercise, vitamins like D, Zinc & Magnesium. And Methylene Blue, Ivermectin & Fenbendazole. 👇Dr Marik & Dr Kory: Ivermectin For Cancer👇 👇Dr Marik et al: Hybrid Cancer Treatment Protocol👇 👇Dr Marik: Metabolic Cancer Treatment Book👇 Speaker: drpaulmarik Video: Wellness Radar

Valerie Anne Smith

1,006,653 Aufrufe • vor 1 Jahr

"Biopsies Spread Cancer...Biopsies Are The Kiss Of Death. The Needle Punches A Hole In The Tumor, Dragging Cancer Cells & Spreading Them." Dr Ben Johnson Doctors Finally Admit That The Very Test Being Pushed On Patients Is Causing Cancer To Metastasize All Throughout The Body. The body self-contains a tumor within a fibrin sheath. A needle biopsy breaks the seal of the tumor that kept it contained & allows the pathogenic toxins &/or parasites to be unleashed. When a hornet's nest is poked, it doesn't calm the hive...it angers & scatters. That’s what happens when a needle pierces a tumor. Cancer cells are dragged into new territory, inflammation flares, the immune system gets distracted, and the “nest” gets angrier. Cells are dragged along the needle tract. Local inflammation activates tumor growth. The immune system is suppressed & cancer cells invade tissue, blood & lymph. Biopsies trigger metastasis, inflammation & tumor seeding: "Biopsy of primary tumors resulted in significantly increased incidence & number of lung metastasis."(PMID 25061543) "Biopsies promote intraperitoneal tumor dissemination & progression." (PMID 23258276) "Core needle biopsy of breast tumors increases distant metastases. (PMID 25425969) "Biopsies lead to tumor cell dissemination & seeding of malignant tumors." (PMID 22686607) "Human breast cancer biopsies enhance adjacent cancer cell proliferation." (PMID 27249999) Top Doctors Are Now Admitting 'That Standard Of Care' Is Killing Patients: "Manipulation of an intact tumor...is associated with an increase in the incidence of sentinel node metastasis." (John Wayne Cancer Institute 2022) "Cutting out a section...endangered the person's life by aggravating the malignant growth." (Dr Perry Nichols) "Biopsies spread early cancers." (Dr Jonathan Wright) "Biopsies introduce cancer cells into the bloodstream." (Dr Leonard Gomella) "Biopsies cause cancer cells to spread & the risk is higher in certain types of cancers like prostate & kidney cancers." (Dr Hal Schofield) "Biopsies cause cancer to disseminate further into the body & this has serious implications to patient outcomes." (Dr Robert Nagourney) Alternative Tests That Do Not Disturb Fibrin Sheath Of The Encapsulated Tumor: 1⃣ Multiparametric MRI (pmMRI): Non-invasive. No ionizing radiation. Detects structure & function in high resolution. 2⃣ Color Doppler Ultrasound: Maps tumor blood flow in real time. No radiation. No compression damage. 3⃣ Liquid Biopsy (ctDNA /CTC Testing): Blood test for cancer DNA or cells. No mechanical disruption of tumors. 4⃣ Thermography: Non-radiation, non-invasive technique that uses infrared cameras to detect heat patterns in tumors. Information is anti-fear. Knowledge is power. It gives you choices. It gives you power. If you’ve been diagnosed, please don’t rush. Research. Ask questions. Trust your intuition. Sometimes slowing down is the most urgent thing you can do. The cancer industrial complex is a powerful profit model & needs a massive overhaul. Too many patients blindly walk into these procedures without informed consent, never being told the risks. You can choose to not disturb the tumor at all & instead implement a protocol to shrink & enable the body to eradicate the tumor all together. Many cases of cancer tumors are actually parasitic eggs sacs misdiagnosed as cancer. There are ways to diagnose cancer without the risk of spread & acceleration. And ways to prevent & treat cancer without the harm of Chemotherapy & Radiation. There is a groundbreaking protocol by Dr William Makis, Dr Paul Marik & others that uses Ivermectin, Fenbendazole, Methylene Blue, Fasting, Ketogenic Diet & other proven cancer remission strategies that addresses cancer & parasites simultaneously. ⏩ ⏪ 👇Seeding Tumor Cells Into Metastasis👇 👇Needle Biopsy Promotes Metastasis👇 👇Needle Biopsy Accelerates Cancer👇 Speaker: Justin Stellman

"Biopsies Spread Cancer...Biopsies Are The Kiss Of Death. The Needle Punches A Hole In The Tumor, Dragging Cancer Cells & Spreading Them." Dr Ben Johnson Doctors Finally Admit That The Very Test Being Pushed On Patients Is Causing Cancer To Metastasize All Throughout The Body. The body self-contains a tumor within a fibrin sheath. A needle biopsy breaks the seal of the tumor that kept it contained & allows the pathogenic toxins &/or parasites to be unleashed. When a hornet's nest is poked, it doesn't calm the hive...it angers & scatters. That’s what happens when a needle pierces a tumor. Cancer cells are dragged into new territory, inflammation flares, the immune system gets distracted, and the “nest” gets angrier. Cells are dragged along the needle tract. Local inflammation activates tumor growth. The immune system is suppressed & cancer cells invade tissue, blood & lymph. Biopsies trigger metastasis, inflammation & tumor seeding: "Biopsy of primary tumors resulted in significantly increased incidence & number of lung metastasis."(PMID 25061543) "Biopsies promote intraperitoneal tumor dissemination & progression." (PMID 23258276) "Core needle biopsy of breast tumors increases distant metastases. (PMID 25425969) "Biopsies lead to tumor cell dissemination & seeding of malignant tumors." (PMID 22686607) "Human breast cancer biopsies enhance adjacent cancer cell proliferation." (PMID 27249999) Top Doctors Are Now Admitting 'That Standard Of Care' Is Killing Patients: "Manipulation of an intact tumor...is associated with an increase in the incidence of sentinel node metastasis." (John Wayne Cancer Institute 2022) "Cutting out a section...endangered the person's life by aggravating the malignant growth." (Dr Perry Nichols) "Biopsies spread early cancers." (Dr Jonathan Wright) "Biopsies introduce cancer cells into the bloodstream." (Dr Leonard Gomella) "Biopsies cause cancer cells to spread & the risk is higher in certain types of cancers like prostate & kidney cancers." (Dr Hal Schofield) "Biopsies cause cancer to disseminate further into the body & this has serious implications to patient outcomes." (Dr Robert Nagourney) Alternative Tests That Do Not Disturb Fibrin Sheath Of The Encapsulated Tumor: 1⃣ Multiparametric MRI (pmMRI): Non-invasive. No ionizing radiation. Detects structure & function in high resolution. 2⃣ Color Doppler Ultrasound: Maps tumor blood flow in real time. No radiation. No compression damage. 3⃣ Liquid Biopsy (ctDNA /CTC Testing): Blood test for cancer DNA or cells. No mechanical disruption of tumors. 4⃣ Thermography: Non-radiation, non-invasive technique that uses infrared cameras to detect heat patterns in tumors. Information is anti-fear. Knowledge is power. It gives you choices. It gives you power. If you’ve been diagnosed, please don’t rush. Research. Ask questions. Trust your intuition. Sometimes slowing down is the most urgent thing you can do. The cancer industrial complex is a powerful profit model & needs a massive overhaul. Too many patients blindly walk into these procedures without informed consent, never being told the risks. You can choose to not disturb the tumor at all & instead implement a protocol to shrink & enable the body to eradicate the tumor all together. Many cases of cancer tumors are actually parasitic eggs sacs misdiagnosed as cancer. There are ways to diagnose cancer without the risk of spread & acceleration. And ways to prevent & treat cancer without the harm of Chemotherapy & Radiation. There is a groundbreaking protocol by Dr William Makis, Dr Paul Marik & others that uses Ivermectin, Fenbendazole, Methylene Blue, Fasting, Ketogenic Diet & other proven cancer remission strategies that addresses cancer & parasites simultaneously. ⏩ ⏪ 👇Seeding Tumor Cells Into Metastasis👇 👇Needle Biopsy Promotes Metastasis👇 👇Needle Biopsy Accelerates Cancer👇 Speaker: Justin Stellman

Valerie Anne Smith

770,250 Aufrufe • vor 10 Monaten

$Deuterium — a variable almost nobody tracks — regulates cell growth and mitochondrial function. It sits upstream of cancer and everything downstream. Your mitochondria maintain a lower deuterium concentration inside their inner membrane than outside. That gradient is not incidental. It's a feature of normal mitochondrial function. Roman Zubarev — professor of medical proteomics at the Karolinska Institute, trained at Moscow's elite physics institute — has spent years studying what happens when you disturb it. 1. Deuterium As A Cell Growth Regulator Deuterium — heavy hydrogen — regulates cell growth rate in the range of approximately 30–350 ppm. Earth's normal deuterium concentration is around 150 ppm. When cells are deprived of this normal amount, their growth slows down. To test this, Zubarev’s lab used A549 lung cancer cells — currently the most widely used cell line in biology — and exposed them to deuterium-depleted water at about 80 ppm. The result? Cancer cell growth rate dropped by 30%. Once deuterium concentrations step outside of that 30–350 ppm regulatory window, the effects stop being regulatory and start becoming highly detrimental. For example Mars carries approximately 750–1,050 ppm of deuterium—roughly 5 to 7 times Earth's natural concentration. When terrestrial organisms are exposed to Martian deuterium levels, they show significant survival decline. Zubarev’s team conducted a two-year experiment growing small shrimp in isolated environments where the water was modified to contain ~600 ppm of deuterium. They found that the survival rates of the shrimp significantly declined compared to those grown in normal water. 2. The Mitochondrial Mechanism — How Deuterium Depleted Water (DDW) Actually Works Alongside the well-known proton gradient, there is also a deuterium gradient across the inner mitochondrial membrane. Normally, the concentration of deuterium is lower inside the membrane than it is outside. Mitochondrial lipids are naturally deuterium-depleted. When cells are placed in 80 ppm deuterium-depleted water — lower than the normal ~150 ppm outside — the gradient reverses. More deuterium inside the membrane than outside. So how does this reversal suppress growth? This reversal upsets reactive oxygen species (ROS) production. To try and restore equilibrium, the mitochondria rapidly increase their production of ROS. This sudden spike in ROS induces oxidative stress within the cell, which the researchers identified as the primary molecular mechanism that ultimately suppresses the growth of the cells. This is the anti-cancer mechanism. Zubarev: "We have not invented this mechanism — it's very well known." To prove that DDW suppresses cancer cell growth by inducing oxidative stress they added NAC — N-acetylcysteine, a standard antioxidant — to DDW-treated cancer cells. If DDW works through ROS, an antioxidant should cancel the effect. The result? At approximately 2 millimolar NAC, the DDW anti-cancer effect was statistically eliminated. Then they tested the reverse. They combined DDW with auranofin — a drug that induces oxidative stress. If both work through ROS, combining them should produce synergistic effect. The result? At low to medium concentrations, adding the drug to the DDW created a "double whammy effect" where the cell count went down even further. However, at very high concentrations of the drug, the effect of the DDW diminished, which Zubarev explains makes sense because a cell does not need two overwhelming sources of reactive oxygen species to die. Three-layer validation. Published in Molecular and Cellular Proteomics — the top proteomics journal. 3. The Antioxidant Implication Standard health messaging treats ROS as purely bad. Antioxidants good. Oxidative stress bad. Zubarev's data complicates this directly. DDW works by increasing ROS in cancer cells. Antioxidants statistically cancelled the therapeutic effect. Auranofin — an oxidative stress inducer — synergized with DDW against cancer. Important caveat: this finding is in cancer cells, not in healthy humans. Zubarev notes that normal human cells react differently, stating that normal human cells are much less sensitive to DDW. Therefore, the induction of ROS to slow down growth is a therapeutic mechanism specifically observed in fast-growing cancer cells, not a general effect reported for healthy cells. But the blanket "antioxidants are good" narrative fails here. Context determines whether ROS is friend or enemy. 4. You Are Not What You Eat The standard model of nutrition assumes the body passively absorbs its dietary inputs — including isotopic composition. Zubarev's data shows the opposite. The body actively resists changes to its internal isotopic composition. It defends a specific ratio the way it defends pH or temperature. Isotopes modulate their own fractionation — the biological system selectively processes and separates heavy and light isotopes to maintain equilibrium. The isotopic quality of what you eat and drink is a regulated biological input — not a passive one. For example, the deuterium levels found in the proline, hydroxyproline, and collagen of seals are twice as high as the deuterium levels in the surrounding seawater. Because the isotopic concentration in the seals' biological building blocks is double that of their environment, there is no way to attribute this composition simply to their food. 5. Isotopic Resonance — The Order Underlying Life Plot the isotopic masses and abundances of the elements that make up biological molecules — hydrogen, carbon, nitrogen, oxygen. You'd expect random scatter, a scattered "galaxy" of dots. Instead you find a precise line. Zubarev calls it isotopic resonance. At natural isotopic abundances, biological molecules cluster in a specific ratio that produces the simplest, most efficient molecular conformations. That ratio is the point at which life's chemistry runs fastest. The probability of this pattern appearing by chance is astronomically small. Zubarev — a physicist trained in probability — cannot dismiss it: "This is the line of God, if you want." Life doesn't exist here just because of liquid water and moderate temperature. It exists here because Earth's isotopic composition happens to hit the resonance at which life's machinery runs. Disturb that composition — and the system works to defend it. The isotopic quality of your water, your food, and your environment is not a background variable. It is the upstream input everything else depends on.$

Deuterium — a variable almost nobody tracks — regulates cell growth and mitochondrial function. It sits upstream of cancer and everything downstream. Your mitochondria maintain a lower deuterium concentration inside their inner membrane than outside. That gradient is not incidental. It's a feature of normal mitochondrial function. Roman Zubarev — professor of medical proteomics at the Karolinska Institute, trained at Moscow's elite physics institute — has spent years studying what happens when you disturb it. 1. Deuterium As A Cell Growth Regulator Deuterium — heavy hydrogen — regulates cell growth rate in the range of approximately 30–350 ppm. Earth's normal deuterium concentration is around 150 ppm. When cells are deprived of this normal amount, their growth slows down. To test this, Zubarev’s lab used A549 lung cancer cells — currently the most widely used cell line in biology — and exposed them to deuterium-depleted water at about 80 ppm. The result? Cancer cell growth rate dropped by 30%. Once deuterium concentrations step outside of that 30–350 ppm regulatory window, the effects stop being regulatory and start becoming highly detrimental. For example Mars carries approximately 750–1,050 ppm of deuterium—roughly 5 to 7 times Earth's natural concentration. When terrestrial organisms are exposed to Martian deuterium levels, they show significant survival decline. Zubarev’s team conducted a two-year experiment growing small shrimp in isolated environments where the water was modified to contain ~600 ppm of deuterium. They found that the survival rates of the shrimp significantly declined compared to those grown in normal water. 2. The Mitochondrial Mechanism — How Deuterium Depleted Water (DDW) Actually Works Alongside the well-known proton gradient, there is also a deuterium gradient across the inner mitochondrial membrane. Normally, the concentration of deuterium is lower inside the membrane than it is outside. Mitochondrial lipids are naturally deuterium-depleted. When cells are placed in 80 ppm deuterium-depleted water — lower than the normal ~150 ppm outside — the gradient reverses. More deuterium inside the membrane than outside. So how does this reversal suppress growth? This reversal upsets reactive oxygen species (ROS) production. To try and restore equilibrium, the mitochondria rapidly increase their production of ROS. This sudden spike in ROS induces oxidative stress within the cell, which the researchers identified as the primary molecular mechanism that ultimately suppresses the growth of the cells. This is the anti-cancer mechanism. Zubarev: "We have not invented this mechanism — it's very well known." To prove that DDW suppresses cancer cell growth by inducing oxidative stress they added NAC — N-acetylcysteine, a standard antioxidant — to DDW-treated cancer cells. If DDW works through ROS, an antioxidant should cancel the effect. The result? At approximately 2 millimolar NAC, the DDW anti-cancer effect was statistically eliminated. Then they tested the reverse. They combined DDW with auranofin — a drug that induces oxidative stress. If both work through ROS, combining them should produce synergistic effect. The result? At low to medium concentrations, adding the drug to the DDW created a "double whammy effect" where the cell count went down even further. However, at very high concentrations of the drug, the effect of the DDW diminished, which Zubarev explains makes sense because a cell does not need two overwhelming sources of reactive oxygen species to die. Three-layer validation. Published in Molecular and Cellular Proteomics — the top proteomics journal. 3. The Antioxidant Implication Standard health messaging treats ROS as purely bad. Antioxidants good. Oxidative stress bad. Zubarev's data complicates this directly. DDW works by increasing ROS in cancer cells. Antioxidants statistically cancelled the therapeutic effect. Auranofin — an oxidative stress inducer — synergized with DDW against cancer. Important caveat: this finding is in cancer cells, not in healthy humans. Zubarev notes that normal human cells react differently, stating that normal human cells are much less sensitive to DDW. Therefore, the induction of ROS to slow down growth is a therapeutic mechanism specifically observed in fast-growing cancer cells, not a general effect reported for healthy cells. But the blanket "antioxidants are good" narrative fails here. Context determines whether ROS is friend or enemy. 4. You Are Not What You Eat The standard model of nutrition assumes the body passively absorbs its dietary inputs — including isotopic composition. Zubarev's data shows the opposite. The body actively resists changes to its internal isotopic composition. It defends a specific ratio the way it defends pH or temperature. Isotopes modulate their own fractionation — the biological system selectively processes and separates heavy and light isotopes to maintain equilibrium. The isotopic quality of what you eat and drink is a regulated biological input — not a passive one. For example, the deuterium levels found in the proline, hydroxyproline, and collagen of seals are twice as high as the deuterium levels in the surrounding seawater. Because the isotopic concentration in the seals' biological building blocks is double that of their environment, there is no way to attribute this composition simply to their food. 5. Isotopic Resonance — The Order Underlying Life Plot the isotopic masses and abundances of the elements that make up biological molecules — hydrogen, carbon, nitrogen, oxygen. You'd expect random scatter, a scattered "galaxy" of dots. Instead you find a precise line. Zubarev calls it isotopic resonance. At natural isotopic abundances, biological molecules cluster in a specific ratio that produces the simplest, most efficient molecular conformations. That ratio is the point at which life's chemistry runs fastest. The probability of this pattern appearing by chance is astronomically small. Zubarev — a physicist trained in probability — cannot dismiss it: "This is the line of God, if you want." Life doesn't exist here just because of liquid water and moderate temperature. It exists here because Earth's isotopic composition happens to hit the resonance at which life's machinery runs. Disturb that composition — and the system works to defend it. The isotopic quality of your water, your food, and your environment is not a background variable. It is the upstream input everything else depends on.

no.mind

29,438 Aufrufe • vor 2 Monaten